GRITSTONE ONCOLOGY INC's ticker is GRTS and the CUSIP is 39868T105. A total of 70 filers reported holding GRITSTONE ONCOLOGY INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $70,590 | -69.4% | 36,200 | -56.3% | 0.00% | -100.0% |
Q1 2023 | $230,462 | -67.5% | 82,900 | -59.7% | 0.00% | -50.0% |
Q4 2022 | $709,682 | +21.1% | 205,705 | -9.8% | 0.00% | 0.0% |
Q3 2022 | $586,000 | +41.5% | 227,944 | +33.2% | 0.00% | +100.0% |
Q2 2022 | $414,000 | +216.0% | 171,104 | +438.9% | 0.00% | – |
Q1 2022 | $131,000 | -96.4% | 31,753 | -92.0% | 0.00% | -100.0% |
Q2 2021 | $3,621,000 | +58.3% | 396,659 | +63.5% | 0.01% | +33.3% |
Q1 2021 | $2,288,000 | +208.4% | 242,599 | +117.1% | 0.01% | +50.0% |
Q2 2020 | $742,000 | +466.4% | 111,760 | +395.7% | 0.00% | +300.0% |
Q1 2020 | $131,000 | -7.1% | 22,548 | +43.2% | 0.00% | – |
Q4 2019 | $141,000 | -30.5% | 15,750 | -13.5% | 0.00% | -100.0% |
Q2 2019 | $203,000 | – | 18,206 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Versant Venture Management, LLC | 3,561,150 | $9,152,000 | 15.60% |
Frazier Life Sciences Management, L.P. | 5,237,348 | $13,460,000 | 1.04% |
Redmile Group, LLC | 6,952,760 | $17,869,000 | 0.69% |
Palo Alto Investors LP | 2,330,504 | $5,989,000 | 0.47% |
ACT CAPITAL MANAGEMENT, LLC | 47,500 | $122,000 | 0.17% |
SkyOak Wealth, LLC | 132,851 | $341,000 | 0.12% |
Artal Group S.A. | 750,000 | $1,928,000 | 0.08% |
CORNERCAP INVESTMENT COUNSEL INC | 77,046 | $198,000 | 0.04% |
CAXTON ASSOCIATES LP | 95,190 | $245,000 | 0.03% |
XTX Topco Ltd | 50,517 | $130,000 | 0.03% |